Oncology
 |
|
11 february 2019 18:00:10 |
| The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance (Oncogene) |
|
Tweet |
| 60 viewsCategory: Oncology |
 MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial (British Journal of Cancer)Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy (Oncogene) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
